For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
3G and Supplementary Fig
For example, excessive intake may lead to unpleasant symptoms such as diarrhea, nausea, vomiting, headache and muscle cramps
The antioxidant-rich formulation helps support clearer skin by reducing oxidative stress that may contribute to acne, dryness, and sensitivity
This can help stabilize blood sugar and may benefit those with diabetes or at risk of developing it